{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T20:11:53Z","timestamp":1790107913654,"version":"4.0.1"},"reference-count":71,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82504810"],"award-info":[{"award-number":["82504810"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82606918"],"award-info":[{"award-number":["82606918"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.bcp.2026.118461","type":"journal-article","created":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T14:56:34Z","timestamp":1789052194000},"page":"118461","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"P2","title":["Beyond neurotransmission: A hypothetical framework for non-canonical dopamine receptor signaling in lung cancer pathobiology and therapy resistance"],"prefix":"10.1016","volume":"254","author":[{"given":"Donghong","family":"Yuan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qijie","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangxiu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.bcp.2026.118461_b0005","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA. Cancer J. Clin."},{"issue":"12","key":"10.1016\/j.bcp.2026.118461_b0010","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1016\/j.annonc.2021.08.2151","article-title":"Clinical definition of acquired resistance to immunotherapy in patients with metastatic non-small-cell lung cancer","volume":"32","author":"Schoenfeld","year":"2021","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.bcp.2026.118461_b0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2025.104958","article-title":"Dynamic interplay of neuroendocrine signaling and immuno-surveillance in tumor niche remodeling","volume":"216","author":"Xu","year":"2025","journal-title":"Crit. Rev. Oncol. Hematol."},{"issue":"6","key":"10.1016\/j.bcp.2026.118461_b0020","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1002\/1878-0261.13608","article-title":"DRD1 suppresses cell proliferation and reduces EGFR activation and PD-L1 expression in NSCLC","volume":"18","author":"Grant","year":"2024","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.bcp.2026.118461_b0025","doi-asserted-by":"crossref","unstructured":"S.K. Alam, A. Pandit, L. Wang, S.S. Mortazavi Farsani, B.A. Thiele, P. Manoj, M.C. Aubry, V. Verma, C.M. Rudin, Y.C. Lo, L.H. Hoeppner, Dopamine D(2) receptor agonists abrogate neuroendocrine tumour angiogenesis to inhibit chemotherapy-refractory small cell lung cancer progression, Cell Death Dis. 16 (1) (2025) 370, https:\/\/doi.org\/10.1038\/s41419-025-07693-y.","DOI":"10.1038\/s41419-025-07693-y"},{"issue":"4","key":"10.1016\/j.bcp.2026.118461_b0030","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1124\/molpharm.121.000336","article-title":"Pharmacological Characterization of the Imipridone Anticancer Drug ONC201 Reveals a Negative Allosteric Mechanism of Action at the D(2) Dopamine Receptor","volume":"100","author":"Free","year":"2021","journal-title":"Mol. Pharmacol."},{"issue":"1","key":"10.1016\/j.bcp.2026.118461_b0035","doi-asserted-by":"crossref","first-page":"489","DOI":"10.7314\/APJCP.2014.15.1.489","article-title":"Anti-tumor effects of penfluridol through dysregulation of cholesterol homeostasis","volume":"15","author":"Wu","year":"2014","journal-title":"Asian Pac. J. Cancer Prev."},{"issue":"1","key":"10.1016\/j.bcp.2026.118461_b0040","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1124\/pr.110.002642","article-title":"The physiology, signaling, and pharmacology of dopamine receptors","volume":"63","author":"Beaulieu","year":"2011","journal-title":"Pharmacol. Rev."},{"issue":"1","key":"10.1016\/j.bcp.2026.118461_b0045","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1152\/physrev.1998.78.1.189","article-title":"Dopamine receptors: from structure to function","volume":"78","author":"Missale","year":"1998","journal-title":"Physiol. Rev."},{"issue":"1","key":"10.1016\/j.bcp.2026.118461_b0050","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s10571-018-0632-3","article-title":"Dopamine: Functions, Signaling, and Association with Neurological Diseases","volume":"39","author":"Klein","year":"2019","journal-title":"Cell. Mol. Neurobiol."},{"issue":"1","key":"10.1016\/j.bcp.2026.118461_b0055","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s12931-018-0757-4","article-title":"The dopamine D(1) receptor is expressed and induces CREB phosphorylation and MUC5AC expression in human airway epithelium","volume":"19","author":"Matsuyama","year":"2018","journal-title":"Respir. Res."},{"issue":"10","key":"10.1016\/j.bcp.2026.118461_b0060","doi-asserted-by":"crossref","DOI":"10.3390\/ph16101427","article-title":"Modulation of Neuron and Astrocyte Dopamine Receptors via Receptor-Receptor Interactions","volume":"16","author":"Guidolin","year":"2023","journal-title":"Pharmaceuticals (Basel)"},{"issue":"1","key":"10.1016\/j.bcp.2026.118461_b0065","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.biopsych.2016.10.011","article-title":"New Concepts in Dopamine D(2) Receptor Biased Signaling and Implications for Schizophrenia Therapy","volume":"81","author":"Urs","year":"2017","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.bcp.2026.118461_b0070","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.neuropharm.2015.05.028","article-title":"Allosteric mechanisms within the adenosine A2A-dopamine D2 receptor heterotetramer","volume":"104","author":"Ferre","year":"2016","journal-title":"Neuropharmacology"},{"issue":"2","key":"10.1016\/j.bcp.2026.118461_b0075","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1073\/pnas.0604049104","article-title":"D1-D2 dopamine receptor heterooligomers with unique pharmacology are coupled to rapid activation of Gq\/11 in the striatum","volume":"104","author":"Rashid","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"7","key":"10.1016\/j.bcp.2026.118461_b0080","article-title":"Action Potential Firing Patterns Regulate Dopamine Release via Voltage-Sensitive Dopamine D2 Autoreceptors in Mouse Striatum In Vivo","volume":"12","author":"Sun","year":"2025","journal-title":"Adv Sci (Weinh)"},{"key":"10.1016\/j.bcp.2026.118461_b0085","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.959500","article-title":"Expression, correlation, and prognostic significance of different nicotinic acetylcholine receptors, programed death ligand 1, and dopamine receptor D2 in lung adenocarcinoma","volume":"12","author":"Pal","year":"2022","journal-title":"Front. Oncol."},{"issue":"7","key":"10.1016\/j.bcp.2026.118461_b0090","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1097\/CAD.0b013e3280b10d36","article-title":"D2 dopamine receptor-mediated antiproliferation in a small cell lung cancer cell line, NCI-H69","volume":"18","author":"Senogles","year":"2007","journal-title":"Anticancer. Drugs"},{"issue":"2","key":"10.1016\/j.bcp.2026.118461_b0095","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1177\/039463201302600212","article-title":"A novel report of apoptosis in human lung carcinoma cells using selective agonist of D2-like dopamine receptors: a new approach for the treatment of human non-small cell lung cancer","volume":"26","author":"Sheikhpour","year":"2013","journal-title":"Int. J. Immunopathol. Pharmacol."},{"issue":"6","key":"10.1016\/j.bcp.2026.118461_b0100","doi-asserted-by":"crossref","first-page":"2258","DOI":"10.1159\/000492644","article-title":"Overexpressed D2 Dopamine Receptor Inhibits Non-Small Cell Lung Cancer Progression through Inhibiting NF-kappaB Signaling Pathway","volume":"48","author":"Wu","year":"2018","journal-title":"Cell. Physiol. Biochem."},{"issue":"11","key":"10.1016\/j.bcp.2026.118461_b0105","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0207204","article-title":"Association of specific gene mutations derived from machine learning with survival in lung adenocarcinoma","volume":"13","author":"Cho","year":"2018","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.bcp.2026.118461_b0110","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.lungcan.2006.11.007","article-title":"Polymorphisms of dopamine receptor\/transporter genes and risk of non-small cell lung cancer","volume":"56","author":"Campa","year":"2007","journal-title":"Lung Cancer"},{"issue":"8","key":"10.1016\/j.bcp.2026.118461_b0115","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1038\/s41422-023-00808-0","article-title":"Structural genomics of the human dopamine receptor system","volume":"33","author":"Xu","year":"2023","journal-title":"Cell Res."},{"key":"10.1016\/j.bcp.2026.118461_b0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.biocel.2022.106235","article-title":"Dopamine D(1) receptor-mediated beta-arrestin signaling: Insight from pharmacology, biology, behavior, and neurophysiology","volume":"148","author":"Yang","year":"2022","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.bcp.2026.118461_b0125","doi-asserted-by":"crossref","first-page":"8202","DOI":"10.1038\/ncomms9202","article-title":"Phospho-selective mechanisms of arrestin conformations and functions revealed by unnatural amino acid incorporation and (19)F-NMR","volume":"6","author":"Yang","year":"2015","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.bcp.2026.118461_b0130","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1038\/s41467-020-14788-x","article-title":"Pyridoxine induces glutathione synthesis via PKM2-mediated Nrf2 transactivation and confers neuroprotection","volume":"11","author":"Wei","year":"2020","journal-title":"Nat. Commun."},{"issue":"11","key":"10.1016\/j.bcp.2026.118461_b0135","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1038\/s41418-018-0127-2","article-title":"Dopamine D2 receptor restricts astrocytic NLRP3 inflammasome activation via enhancing the interaction of beta-arrestin2 and NLRP3","volume":"25","author":"Zhu","year":"2018","journal-title":"Cell Death Differ."},{"issue":"1","key":"10.1016\/j.bcp.2026.118461_b0140","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1186\/s12974-022-02597-6","article-title":"beta-Arrestin2-biased Drd2 agonist UNC9995 alleviates astrocyte inflammatory injury via interaction between beta-arrestin2 and STAT3 in mouse model of depression","volume":"19","author":"Liu","year":"2022","journal-title":"J. Neuroinflammation"},{"issue":"6","key":"10.1016\/j.bcp.2026.118461_b0145","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1159\/000509219","article-title":"Beta-Arrestin 2 Is Required for Dopamine Receptor Type 2 Inhibitory Effects on AKT Phosphorylation and Cell Proliferation in Pituitary Tumors","volume":"111","author":"Mangili","year":"2021","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.bcp.2026.118461_b0150","doi-asserted-by":"crossref","unstructured":"T. Weiss-Sadan, M. Ge, M. Hayashi, M. Gohar, C.H. Yao, A. de Groot, S. Harry, A. Carlin, H. Fischer, L. Shi, T.Y. Wei, C.H. Adelmann, K. Wolf, T. Vornbaumen, B.R. Durr, M. Takahashi, M. Richter, J. Zhang, T.Y. Yang, V. Vijay, D.E. Fisher, A.N. Hata, M.C. Haigis, R. Mostoslavsky, N. Bardeesy, T. Papagiannakopoulos, L. Bar-Peled, NRF2 activation induces NADH-reductive stress, providing a metabolic vulnerability in lung cancer, Cell Metab. 35 (3) (2023) 487\u2013503. e487, https:\/\/doi.org\/10.1016\/j.cmet.2023.01.012.","DOI":"10.1016\/j.cmet.2023.01.012"},{"key":"10.1016\/j.bcp.2026.118461_b0155","article-title":"Neutrophil Extracellular Traps (NETs) Promote Non-Small Cell Lung Cancer Metastasis by Suppressing lncRNA MIR503HG to Activate the NF-kappaB\/NLRP3 Inflammasome Pathway","volume":"13","author":"Wang","year":"2022","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.bcp.2026.118461_b0160","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1017\/S0952523805221089","article-title":"Reciprocal inhibition of voltage-gated potassium currents (I K(V)) by activation of cannabinoid CB1 and dopamine D1 receptors in ON bipolar cells of goldfish retina","volume":"22","author":"Fan","year":"2005","journal-title":"Vis. Neurosci."},{"key":"10.1016\/j.bcp.2026.118461_b0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2023.106341","article-title":"Boolean analysis shows a high proportion of dopamine D(2) receptors interacting with adenosine A(2A) receptors in striatal medium spiny neurons of mouse and non-human primate models of Parkinson's disease","volume":"188","author":"Rivas-Santisteban","year":"2023","journal-title":"Neurobiol. Dis."},{"issue":"2","key":"10.1016\/j.bcp.2026.118461_b0170","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1007\/s12035-018-1120-y","article-title":"Adenosine A(1)-Dopamine D(1) Receptor Heteromers Control the Excitability of the Spinal Motoneuron","volume":"56","author":"Rivera-Oliver","year":"2019","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.bcp.2026.118461_b0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2025.101272","article-title":"Metabolic reprogramming of tumor-associated macrophages via adenosine-A(2A)R signaling drives cross-resistance in non-small cell lung cancer","volume":"82","author":"Ding","year":"2025","journal-title":"Drug Resist. Updat."},{"issue":"2","key":"10.1016\/j.bcp.2026.118461_b0180","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1124\/mol.113.085175","article-title":"D1-D2 dopamine receptor synergy promotes calcium signaling via multiple mechanisms","volume":"84","author":"Chun","year":"2013","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.bcp.2026.118461_b0185","doi-asserted-by":"crossref","unstructured":"Y. Zhuang, P. Xu, C. Mao, L. Wang, B. Krumm, X.E. Zhou, S. Huang, H. Liu, X. Cheng, X.P. Huang, D.D. Shen, T. Xu, Y.F. Liu, Y. Wang, J. Guo, Y. Jiang, H. Jiang, K. Melcher, B.L. Roth, Y. Zhang, C. Zhang, H.E. Xu, Structural insights into the human D1 and D2 dopamine receptor signaling complexes, Cell 184 (4) (2021) 931\u2013942. e918, https:\/\/doi.org\/10.1016\/j.cell.2021.01.027.","DOI":"10.1016\/j.cell.2021.01.027"},{"key":"10.1016\/j.bcp.2026.118461_b0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2020.105017","article-title":"Dopamine D1-D2 receptor heteromer expression in key brain regions of rat and higher species: Upregulation in rat striatum after cocaine administration","volume":"143","author":"Hasbi","year":"2020","journal-title":"Neurobiol. Dis."},{"issue":"11","key":"10.1016\/j.bcp.2026.118461_b0195","doi-asserted-by":"crossref","first-page":"4806","DOI":"10.1096\/fj.14-254037","article-title":"A peptide targeting an interaction interface disrupts the dopamine D1-D2 receptor heteromer to block signaling and function in vitro and in vivo: effective selective antagonism","volume":"28","author":"Hasbi","year":"2014","journal-title":"FASEB J."},{"issue":"4","key":"10.1016\/j.bcp.2026.118461_b0200","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.7150\/jca.91129","article-title":"Blockade of spinal dopamine D1\/D2 receptor heteromers by levo-Corydalmine suppressed calcium signaling cascade in spinal neurons to alleviate bone cancer pain in rats","volume":"15","author":"Ma","year":"2024","journal-title":"J. Cancer"},{"issue":"2","key":"10.1016\/j.bcp.2026.118461_b0205","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1021\/cb5007568","article-title":"Time-resolved FRET binding assay to investigate hetero-oligomer binding properties: proof of concept with dopamine D1\/D3 heterodimer","volume":"10","author":"Hounsou","year":"2015","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.bcp.2026.118461_b0210","doi-asserted-by":"crossref","unstructured":"D. Marcellino, S. Ferre, V. Casado, A. Cortes, B. Le Foll, C. Mazzola, F. Drago, O. Saur, H. Stark, A. Soriano, C. Barnes, S.R. Goldberg, C. Lluis, K. Fuxe, R. Franco, Identification of dopamine D1-D3 receptor heteromers. Indications for a role of synergistic D1-D3 receptor interactions in the striatum, J. Biol. Chem. 283 (38) (2008) 26016\u201326025, https:\/\/doi.org\/10.1074\/jbc.M710349200.","DOI":"10.1074\/jbc.M710349200"},{"issue":"3","key":"10.1016\/j.bcp.2026.118461_b0215","doi-asserted-by":"crossref","DOI":"10.3390\/biom13030473","article-title":"G Protein-Dependent Activation of the PKA-Erk1\/2 Pathway by the Striatal Dopamine D1\/D3 Receptor Heteromer Involves Beta-Arrestin and the Tyrosine Phosphatase Shp-2","volume":"13","author":"Bono","year":"2023","journal-title":"Biomolecules"},{"key":"10.1016\/j.bcp.2026.118461_b0220","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2025.107826","article-title":"Locomotor activity depends on beta-arrestin recruitment by the dopamine D(1) receptor in the striatal D(1)-D(3) receptor heteromer","volume":"218","author":"Evans","year":"2025","journal-title":"Pharmacol. Res."},{"issue":"3","key":"10.1016\/j.bcp.2026.118461_b0225","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1007\/s12035-014-8936-x","article-title":"Stronger Dopamine D1 Receptor-Mediated Neurotransmission in Dyskinesia","volume":"52","author":"Farre","year":"2015","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.bcp.2026.118461_b0230","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.nbd.2018.09.018","article-title":"5alpha-reductase inhibitors dampen L-DOPA-induced dyskinesia via normalization of dopamine D1-receptor signaling pathway and D1-D3 receptor interaction","volume":"121","author":"Fanni","year":"2019","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.bcp.2026.118461_b0235","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.neubiorev.2018.03.020","article-title":"Dopamine D1 and D3 receptor polypharmacology as a potential treatment approach for substance use disorder","volume":"89","author":"Galaj","year":"2018","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"4","key":"10.1016\/j.bcp.2026.118461_b0240","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/j.neuropharm.2011.05.023","article-title":"Functional crosstalk and heteromerization of serotonin 5-HT2A and dopamine D2 receptors","volume":"61","author":"Albizu","year":"2011","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.bcp.2026.118461_b0245","first-page":"49","article-title":"Expression of 5-HT2A receptors in prefrontal cortex pyramidal neurons projecting to nucleus accumbens","volume":"79","author":"Mocci","year":"2014","journal-title":"Potential relevance for atypical antipsychotic action, Neuropharmacology"},{"issue":"8","key":"10.1016\/j.bcp.2026.118461_b0250","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1038\/s41401-023-01063-0","article-title":"Quinpirole ameliorates nigral dopaminergic neuron damage in Parkinson's disease mouse model through activating GHS-R1a\/D(2)R heterodimers","volume":"44","author":"Tang","year":"2023","journal-title":"Acta Pharmacol. Sin."},{"issue":"7","key":"10.1016\/j.bcp.2026.118461_b0255","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1016\/S1567-5769(01)00068-6","article-title":"Circulating dopamine level, in lung carcinoma patients, inhibits proliferation and cytotoxicity of CD4+ and CD8+ T cells by D1 dopamine receptors: an in vitro analysis","volume":"1","author":"Saha","year":"2001","journal-title":"Int. Immunopharmacol."},{"issue":"2","key":"10.1016\/j.bcp.2026.118461_b0260","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1074\/jbc.M116.748970","article-title":"Activation of D2 Dopamine Receptors in CD133+ve Cancer Stem Cells in Non-small Cell Lung Carcinoma Inhibits Proliferation, Clonogenic Ability, and Invasiveness of These Cells","volume":"292","author":"Roy","year":"2017","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.bcp.2026.118461_b0265","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.molonc.2014.08.008","article-title":"Dopamine D2 receptor agonists inhibit lung cancer progression by reducing angiogenesis and tumor infiltrating myeloid derived suppressor cells","volume":"9","author":"Hoeppner","year":"2015","journal-title":"Mol. Oncol."},{"issue":"20","key":"10.1016\/j.bcp.2026.118461_b0270","doi-asserted-by":"crossref","first-page":"5353","DOI":"10.1158\/0008-5472.CAN-21-1043","article-title":"Psychologic Stress Drives Progression of Malignant Tumors via DRD2\/HIF1alpha Signaling","volume":"81","author":"Liu","year":"2021","journal-title":"Cancer Res."},{"key":"10.1016\/j.bcp.2026.118461_b0275","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.canlet.2017.03.015","article-title":"The dopamine D(3) receptor antagonists PG01037, NGB2904, SB277011A, and U99194 reverse ABCG2 transporter-mediated drug resistance in cancer cell lines","volume":"396","author":"Hussein","year":"2017","journal-title":"Cancer Lett."},{"issue":"9","key":"10.1016\/j.bcp.2026.118461_b0280","doi-asserted-by":"crossref","DOI":"10.3390\/cancers10090308","article-title":"A Dopamine D(2)\/D(3) Receptor Partial Agonist, Modulates ABCG2-Mediated Multidrug Resistance in Cancer","volume":"10","author":"Hussein","year":"2018","journal-title":"Cancers (Basel)"},{"issue":"7","key":"10.1016\/j.bcp.2026.118461_b0285","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1038\/s41419-024-06848-7","article-title":"Selective PI3Kdelta inhibitor TYM-3-98 suppresses AKT\/mTOR\/SREBP1-mediated lipogenesis and promotes ferroptosis in KRAS-mutant colorectal cancer","volume":"15","author":"Zheng","year":"2024","journal-title":"Cell Death Dis."},{"issue":"7","key":"10.1016\/j.bcp.2026.118461_b0290","doi-asserted-by":"crossref","first-page":"2861","DOI":"10.21873\/anticanres.17098","article-title":"SIRT4 Has an Anti-Cancer Role in Cervical Cancer by Inhibiting Glutamine Metabolism via the MEK\/ERK\/C-Myc Axis","volume":"44","author":"Zhang","year":"2024","journal-title":"Anticancer Res."},{"issue":"1","key":"10.1016\/j.bcp.2026.118461_b0295","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1186\/s13046-023-02728-8","article-title":"Chronic stress accelerates glioblastoma progression via DRD2\/ERK\/beta-catenin axis and Dopamine\/ERK\/TH positive feedback loop","volume":"42","author":"Wang","year":"2023","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"4","key":"10.1016\/j.bcp.2026.118461_b0300","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1091\/mbc.e06-07-0593","article-title":"Cytokine stimulation promotes glucose uptake via phosphatidylinositol-3 kinase\/Akt regulation of Glut1 activity and trafficking","volume":"18","author":"Wieman","year":"2007","journal-title":"Mol. Biol. Cell"},{"issue":"3","key":"10.1016\/j.bcp.2026.118461_b0305","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.cmet.2008.07.007","article-title":"SREBP activity is regulated by mTORC1 and contributes to Akt-dependent cell growth","volume":"8","author":"Porstmann","year":"2008","journal-title":"Cell Metab."},{"issue":"8","key":"10.1016\/j.bcp.2026.118461_b0310","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.tibs.2010.05.003","article-title":"Glutamine addiction: a new therapeutic target in cancer","volume":"35","author":"Wise","year":"2010","journal-title":"Trends Biochem. Sci."},{"issue":"7239","key":"10.1016\/j.bcp.2026.118461_b0315","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1038\/nature07823","article-title":"c-Myc suppression of miR-23a\/b enhances mitochondrial glutaminase expression and glutamine metabolism","volume":"458","author":"Gao","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.bcp.2026.118461_b0320","doi-asserted-by":"crossref","unstructured":"K.M. Choi, A.J. Haak, A.M. Diaz Espinosa, K.A. Cummins, P.A. Link, A. Aravamudhan, D.K. Wood, D.J. Tschumperlin, GPCR-mediated YAP\/TAZ inactivation in fibroblasts via EPAC1\/2, RAP2C, and MAP4K7, J. Cell. Physiol. 236 (11) (2021) 7759\u20137774, https:\/\/doi.org\/10.1002\/jcp.30459.","DOI":"10.1002\/jcp.30459"},{"issue":"3","key":"10.1016\/j.bcp.2026.118461_b0325","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1007\/s10517-024-06191-z","article-title":"Anticancer Effects of Spiperone in C57BL\/6 Mice with Emphysema and Lung Carcinoma","volume":"177","author":"Ermakova","year":"2024","journal-title":"Bull. Exp. Biol. Med."},{"key":"10.1016\/j.bcp.2026.118461_b0330","doi-asserted-by":"crossref","first-page":"10089","DOI":"10.2147\/IJN.S528334","article-title":"Construction of Active-Passive Dual-Targeted Drug-Loaded Micelle Nanoparticles with Modified Dopamine Molecules for Efficient Anti-Tumor Therapy","volume":"20","author":"Chen","year":"2025","journal-title":"Int. J. Nanomedicine"},{"issue":"29","key":"10.1016\/j.bcp.2026.118461_b0335","doi-asserted-by":"crossref","DOI":"10.1002\/smll.201700623","article-title":"TPGS-Functionalized Polydopamine-Modified Mesoporous Silica as Drug Nanocarriers for Enhanced Lung Cancer Chemotherapy against Multidrug Resistance","volume":"13","author":"Cheng","year":"2017","journal-title":"Small"},{"key":"10.1016\/j.bcp.2026.118461_b0340","article-title":"A Tasquinomod-loaded dopamine-modified pH sensitive hydrogel is effective at inhibiting the proliferation of KRAS mutant lung cancer cells","volume":"20","author":"Xu","year":"2022","journal-title":"J. Appl. Biomater. Funct. Mater."},{"key":"10.1016\/j.bcp.2026.118461_b0345","doi-asserted-by":"crossref","unstructured":"F.M. Kamazani, F. Sotoodehnejad Nematalahi, S.D. Siadat, M. Pornour, M. Sheikhpour, A success targeted nano delivery to lung cancer cells with multi-walled carbon nanotubes conjugated to bromocriptine, Sci. Rep. 11 (1) (2021) 24419, https:\/\/doi.org\/10.1038\/s41598-021-03031-2.","DOI":"10.1038\/s41598-021-03031-2"},{"key":"10.1016\/j.bcp.2026.118461_b0350","doi-asserted-by":"crossref","unstructured":"M. Sakkal, R.W.A. Abdelmoteleb, A. Al Ali, Y.A.B. Jardan, R. Lobenberg, M. Sarfraz, Inhalable nanoparticle-based drug delivery system for non-small cell lung cancer therapy: promises and challenges, Saudi Pharm. J. 33 (6) (2025) 50, https:\/\/doi.org\/10.1007\/s44446-025-00046-y.","DOI":"10.1007\/s44446-025-00046-y"},{"issue":"2","key":"10.1016\/j.bcp.2026.118461_b0355","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0378-5173(99)00296-3","article-title":"Pulmonary delivery of a dopamine D-1 agonist, ABT-431, in dogs and humans","volume":"191","author":"Zheng","year":"1999","journal-title":"Int. J. Pharm."}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295226008002?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295226008002?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T19:50:08Z","timestamp":1790106608000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295226008002"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":71,"alternative-id":["S0006295226008002"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2026.118461","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Beyond neurotransmission: A hypothetical framework for non-canonical dopamine receptor signaling in lung cancer pathobiology and therapy resistance","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2026.118461","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"118461"}}